Palatin Technologies (PTN) Revenue (2010 - 2026)
Palatin Technologies' (PTN) quarterly Revenue came in at $3.9 million in Q1 2026, up 3278.84% quarter-over-quarter from $116036.0 in Q4 2025.
Analysis
Palatin Technologies (PTN) Revenue (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Revenue for 14 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 3576.2% YoY), and the FY2024 full-year result was $4.5 million, down 7.49% from the prior year.
- Revenue advanced to $3.9 million in Q1 2026 per PTN's latest filing, from $116036.0 in the prior quarter.
- Across five years, Revenue topped out at $8.8 million in Q3 2025 and bottomed at $116036.0 in Q4 2025.
- Historically, Revenue has averaged $1.9 million across 5 years, with a median of $1.1 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Revenue soared 1057.39% in 2022, then tumbled 80.14% in 2024.
- Over 5 years, Revenue stood at $1.0 million in 2022, then jumped by 98.18% to $2.0 million in 2023, then sank by 82.79% to $350000.0 in 2024, then slumped by 66.85% to $116036.0 in 2025, then jumped by 3278.84% to $3.9 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $3.9 million, $116036.0, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | 3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.92 Mn |
| Dec 31, 2025 | 116,036.00 |
| Sep 30, 2025 | 8.83 Mn |
| Jun 30, 2024 | 350,000.00 |
| Dec 31, 2023 | 2.03 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 869,654.00 |
| Jun 30, 2022 | 770,738.00 |
| Mar 31, 2022 | 216,097.00 |
| Dec 31, 2021 | 322,140.00 |
| Sep 30, 2021 | 159,482.00 |
| Jun 30, 2021 | -80,504.00 |
| Mar 31, 2021 | 88,741.00 |
| Dec 31, 2020 | 163,971.00 |
| Sep 30, 2020 | 288,560.00 |
| Dec 31, 2019 | 20,610.00 |
| Sep 30, 2019 | 97,379.00 |